January 24, 2022
COVID-19 may have accelerated the adoption of RBQM, but it is the intrinsic benefits that are cementing its continued use.
March 13, 2019
What started as an initiative called Risk-Based Monitoring several years ago is now evolving into Risk-Based Quality Management of clinical trials with a much wider impact to the pharma industry.